Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Stroke

被引：9
|
作者：
Kimura, Genjiro [1 ]
机构：
[1] Japan Org Occupat Hlth & Safety, Asahi Rosai Hosp, Hirako Cho North 61, Owariasahi 4888585, Japan
来源：
CIRCULATION JOURNAL | 2017年 / 81卷 / 06期
关键词：
CARDIOVASCULAR OUTCOMES; EMPAGLIFLOZIN; DISEASE;
D O I：
10.1253/circj.CJ-17-0040
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：898 / 898
页数：1
相关论文
共 50 条
  • [31] Eligibility and Response to Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors Therapy How Useful Are Cardiac Biomarkers?
    Echouffo-Tcheugui, Justin B.
    Selvin, Elizabeth
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (05) : 445 - 447
  • [32] Hepatic expression of sodium-glucose cotransporter 2 (SGLT2) in patients with chronic liver disease
    Nakano, Dan
    Akiba, Jun
    Tsutsumi, Tsubasa
    Kawaguchi, Machiko
    Yoshida, Takafumi
    Koga, Hironori
    Kawaguchi, Takumi
    MEDICAL MOLECULAR MORPHOLOGY, 2022, 55 (04) : 304 - 315
  • [33] Overview of the Clinical Pharmacology of Ertugliflozin, a Novel Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor
    Fediuk, Daryl J.
    Nucci, Gianluca
    Dawra, Vikas Kumar
    Cutler, David L.
    Amin, Neeta B.
    Terra, Steven G.
    Boyd, Rebecca A.
    Krishna, Rajesh
    Sahasrabudhe, Vaishali
    CLINICAL PHARMACOKINETICS, 2020, 59 (08) : 949 - 965
  • [34] Overview of the Clinical Pharmacology of Ertugliflozin, a Novel Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor
    Daryl J. Fediuk
    Gianluca Nucci
    Vikas Kumar Dawra
    David L. Cutler
    Neeta B. Amin
    Steven G. Terra
    Rebecca A. Boyd
    Rajesh Krishna
    Vaishali Sahasrabudhe
    Clinical Pharmacokinetics, 2020, 59 : 949 - 965
  • [35] THE POTENTIAL ROLE OF SODIUM/GLUCOSE COTRANSPORTER 2 (SGLT2) INHIBITORS IN THE TREATMENT OF CYSTINURIA
    Sui, Wilson
    Yang, Heiko
    Desai, Manoj
    Chi, Thomas
    Stoller, Marshall
    JOURNAL OF UROLOGY, 2024, 211 (05): : E421 - E421
  • [36] Sodium-glucose cotransporter 2 inhibitors (SGLT2i): renal implications
    Castaneda, Alejandrina M.
    Dutra-Rufato, Amanda
    Juarez, Maria J.
    Grosembacher, Luis
    Gonzalez-Torres, Henry
    Musso, Carlos G.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (02) : 291 - 299
  • [37] Sodium glucose CoTransporter 2 (SGLT2) inhibitors: Current status and future perspective
    Madaan, Tushar
    Akhtar, Mohd.
    Najmi, Abul Kalam
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 93 : 244 - 252
  • [38] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus
    Mahling, Moritz
    Schork, Anja
    Nadalin, Silvio
    Fritsche, Andreas
    Heyne, Nils
    Guthoff, Martina
    KIDNEY & BLOOD PRESSURE RESEARCH, 2019, 44 (05): : 984 - 992
  • [39] Role of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitors in the Treatment of Type 2 Diabetes
    Abdul-Ghani, Muhammad A.
    Norton, Luke
    DeFronzo, Ralph A.
    ENDOCRINE REVIEWS, 2011, 32 (04) : 515 - 531
  • [40] Comparative effectiveness of cardiovascular outcomes in new users of sodium-glucose cotransporter-2 inhibitors: SGLT2 inhibitors in the real world
    MacIsaac, Richard J.
    Ekinci, Elif I.
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (23)
12345